ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison

Additional Metadata
Keywords	BVS, Everolimus-eluting stent, STEMI
Persistent URL	doi.org/10.1016/j.ijcard.2016.04.016, hdl.handle.net/1765/84975
Journal	International Journal of Cardiology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Brugaletta, S., Gori, T., Low, A. F., Tousek, P., Pinar, E., Gomez-Lara, J., Ortega-Paz, L., Schulz, E., Chan, M., Kocka, V., Hurtado, J., Gomez-Hospital, J.-A., Giacchi, G., Munzel, T., Lee, C.-H., Cequier, A., Valdés, M., Widimsky, P., Serruys, P.& Sabate, M. (2016). ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison. International Journal of Cardiology, 214, 483–484.https://doi.org/10.1016/j.ijcard.2016.04.016

Publication